Low Molecular Weight Heparin Nebulization Attenuates Acute Lung Injury

Low Molecular Weight Heparin Nebulization Attenuates Acute Lung Injury

Background. As acute lung injury (ALI) caused high mortality rate, it is important to explore the protection and treatment of ALI. The aim of the current study is to evaluate the effect of low molecular weight heparin (LMWH) nebulization on attenuating acute lung injury and the associated mechanism....

Full description

Bibliographic Details
Main Authors:	Nianlin Xie, Menglei Huan, Feng Tian, Zhongping Gu, Xiaofei Li
Format:	Article
Language:	English
Published:	Hindawi Limited 2017-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2017/3169179

Similar Items

Inhalational injury management: From intubation to nebulized heparin
by: Nissar Shaikh, et al.
Published: (2020-01-01)

Low molecular weight heparin prevents CLP-Induced acute lung injury in rats by anti-inflammatory coagulation
by: Xiao Lu, et al.
Published: (2013-02-01)

Nebulized Heparin for Post-COVID-19-Related Hypoxia
by: Mehmet Hursitoglu, et al.
Published: (2021-07-01)

Heparin Attenuates Histone-Mediated Cytotoxicity in Septic Acute Kidney Injury
by: Ziyi Wang, et al.
Published: (2020-12-01)

Nebulized Heparin in Burn Patients with Inhalation Trauma—Safety and Feasibility
by: Gerie J. Glas, et al.
Published: (2020-03-01)

Does nebulized heparin have value in acute respiratory distress syndrome patients in the setting of polytrauma
by: Mohamed H. Saleh, et al.
Published: (2017-11-01)

N-acetyl-heparin attenuates acute lung injury caused by acid aspiration mainly by antagonizing histones in mice.
by: Yanlin Zhang, et al.
Published: (2014-01-01)

Early and late pulmonary effects of nebulized LPS in mice: An acute lung injury model.
by: Natália de Souza Xavier Costa, et al.
Published: (2017-01-01)

Commentary: Heparin Attenuates Histone-Mediated Cytotoxicity in Septic Acute Kidney Injury
by: Yupei Li, et al.
Published: (2021-04-01)

Role of nebulized heparin inhalation on mechanically ventilated critically ill patients
by: Randa S. Mohammad, et al.
Published: (2016-06-01)

Nebulization of the acidified sodium nitrite formulation attenuates acute hypoxic pulmonary vasoconstriction
by: Surber Mark W, et al.
Published: (2010-06-01)

Inhibition of trypsin by heparin and dalteparin, a low molecular weight heparin
by: Bosnić Olivera M., et al.
Published: (2009-01-01)

Inhibition of trypsin by heparin and dalteparin, a low molecular weight heparin
by: OLIVERA M. BOSNIĆ, et al.
Published: (2009-04-01)

Assessment of the Safety Profile of Unfractionated Heparin and Low Molecular Weight Heparin
by: Tair-Shin Wang, et al.
Published: (2005)

Negative Effects of SIGIRR on TRAF6 Ubiquitination in Acute Lung Injury In Vitro
by: Feng Tian, et al.
Published: (2020-01-01)

Role of heparin in pulmonary cell populations in an in-vitro model of acute lung injury
by: Marta Camprubí–Rimblas, et al.
Published: (2017-05-01)

Nebulizer therapy for lung diseases
by: G. L. Ignatova, et al.
Published: (2020-08-01)

The effects of low-molecular-weight heparin on lung and pulmonary artery injuries in acute pulmonary embolism rat model via platelet-derived growth factor-β
by: Bing Zhou, et al.
Published: (2017-05-01)

Nebulized fibrinolytic agents improve pulmonary fibrinolysis but not inflammation in rat models of direct and indirect acute lung injury.
by: Jorrit J Hofstra, et al.
Published: (2013-01-01)

Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin
by: Jianle Chen BS, et al.
Published: (2019-04-01)

Effect of nebulized budesonide on respiratory mechanics and oxygenation in acute lung injury/acute respiratory distress syndrome: Randomized controlled study
by: Hatem Saber Mohamed, et al.
Published: (2017-01-01)

Nebulized magnesium sulphate versus nebulized salbutamol in acute bronchial asthma
by: E.A. Abdelnabi, et al.
Published: (2012-07-01)

Arterial indications for the low molecular weight heparins
by: Ageno Walter, et al.
Published: (2001-09-01)

Nebulized phosphodiesterase 3 inhibitor during warm ischemia attenuates pulmonary ischemia-reperfusion injury
by: Zhang, Jitian
Published: (2010)

Does a Nebulized Heparin/N-acetylcysteine Protocol Improve Outcomes in Adult Smoke Inhalation?
by: Natalie S. Kashefi, MS, et al.
Published: (2014-06-01)

Pharmacological and clinical evidence for the use of low-molecular-weight heparins in acute coronary syndromes
by: Guido Aranha Rosito, et al.
Published: (2001-08-01)

The effect of subcutaneous unfractionated heparin and low-molecular weight heparin toward modification of diabetic acute influence on surgical wound healing in rats
by: Shima Shafagh, et al.
Published: (2021-01-01)

Heparin-binding protein in ventilator-induced lung injury
by: Jonas Tydén, et al.
Published: (2018-09-01)

COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
by: Alessandra F. Perna, et al.
Published: (2020-05-01)

Low-molecular-weight heparins in the treatment of venous thromboembolism
by: Huisman Menno V, et al.
Published: (2000-08-01)

Intravitreal low molecular weight heparin in PVR surgery.
by: Kumar Atul, et al.
Published: (2003-01-01)

Low-molecular-weight heparin and unfractionated heparin decrease Th-1, 2, and 17 expressions.
by: Jing-Ning Huang, et al.
Published: (2014-01-01)

IS THE INCIDENCE TREND OF HEPARIN-INDUCED THROMBOCYTOPENIA DECREASED BY THE INCREASED USE OF LOW-MOLECULAR-WEIGHT-HEPARIN?
by: Fahad Al-Eidan
Published: (2015-04-01)

USP compendial methods for analysis of heparin: chromatographic determination of molecular weight distributions for heparin sodium
by: Mulloy, Barbara, et al.
Published: (2016)

Low-molecular-weight heparin reduces hyperoxia-augmented ventilator-induced lung injury via serine/threonine kinase-protein kinase B
by: Huang Chung-Chi, et al.
Published: (2011-07-01)

Low molecular weight heparin versus Unfractionated heparin in patients with non ST-elevation acute coronary syndrome: a randomaized clinical trial
by: Zand parsa A, et al.
Published: (2007-09-01)

Prescribing of Low-Molecular-Weight Heparin and Warfarin in Patients with Acute Venous Thromboembolism and Active Cancer
by: Steward, David W., et al.
Published: (2014)

Efficacy and safety of low-molecular-weight heparin after knee arthroscopy: A meta-analysis.
by: Hai-Feng Huang, et al.
Published: (2018-01-01)

Does the use of postoperative low-molecular-weight heparin in patients with lung cancer increase tube drainage?
by: Hıdır Esme, et al.
Published: (2020-01-01)

Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice
by: Wang Yun-Jie, et al.
Published: (2010-03-01)